Sadhguru Named 'Global Indian of the Year' by Canada India Foundation
Sadhguru's leadership in global ecological efforts—most notably the Conscious Planet – Save Soil movement and Cauvery Calling campaign—has mobilized millions worldwide. These initiatives focus on restoring soil health, promoting agroforestry, and encouraging responsible environmental stewardship, supported by scientific research and policy engagement.
During the award ceremony, Sadhguru announced that the CAD 50,000 honorarium would be donated to Cauvery Calling to further its work in revitalizing the Cauvery River basin. 'This is not recognition for me, but for the thousands of volunteers working relentlessly to serve both people and the planet,' he said.
Beyond environmental causes, Sadhguru's work through the Isha Foundation spans education, rural development, and accessible wellness programs across more than 50 countries. In the U.S., the Foundation operates in 34 states, with its primary center located on the Cumberland Plateau in Tennessee. The institute has become a destination for both spiritual exploration and community engagement, contributing to local economies and tourism.
Leaders from CIF cited Sadhguru's wide-reaching influence across cultural, political, and scientific spheres in selecting him for the honor—highlighting his ability to bridge tradition and innovation on a global stage.
The Canada India Foundation's recognition adds to a growing list of accolades acknowledging Sadhguru's efforts to foster conscious, inclusive, and sustainable solutions for global well-being.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
NFP acquires Tennessee-based Levine Group
Property and casualty broker NFP, a unit of Aon, has acquired Levine Group, a wealth and retirement services company based in Tennessee, US. The financial terms of the transaction have not been disclosed. Levine Group, established in 1963, provides a range of financial services to individuals, families, and businesses in the Nashville area. Its offerings include insurance, employee benefits, retirement plan consulting, and investment management. Following the acquisition, Michael Levine, who leads Levine Group, will join NFP. His role will involve collaboration with NFP Central and West region president Mike Schneider. Trevor Coe and Zach Levine are also set to join NFP, where they will continue their involvement in client service and contribute to business growth. Mike Levine said: 'Our clients have trusted us to guide them through life's most important financial decisions, and that trust means everything. Being part of NFP lets us continue doing what we love, while giving us more tools and support to help even more people.' NFP operates with a workforce of approximately 8,000 employees across the US, Puerto Rico, Canada, the UK, and the Republic of Ireland. The company provides services such as wealth management and retirement plan advisory, among others. Schneider stated: 'I'm thrilled Mike, Trevor, Zach and the entire Levine Group team are joining NFP. They've built a strong reputation for helping people and businesses make smart financial decisions, and we're excited to combine forces. 'Their experience and relationships in the Nashville and surrounding market will help us better serve clients and grow our wealth and retirement business in the region.' In December last year, NFP acquired Salus Group, a US-based company that specialises in providing employee benefits consultancy to credit unions. "NFP acquires Tennessee-based Levine Group " was originally created and published by Life Insurance International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
First Horizon (NYSE:FHN) Reports Q2 In Line With Expectations
Regional banking company First Horizon (NYSE:FHN) met Wall Street's revenue expectations in Q2 CY2025, with sales up 1.8% year on year to $830 million. Its non-GAAP profit of $0.45 per share was 8.2% above analysts' consensus estimates. Is now the time to buy First Horizon? Find out in our full research report. Net Interest Income: $641 million vs analyst estimates of $642.8 million (1.9% year-on-year growth, in line) Net Interest Margin: 3.4% vs analyst estimates of 3.4% (2 basis point year-on-year increase, in line) Revenue: $830 million vs analyst estimates of $827.7 million (1.8% year-on-year growth, in line) Efficiency Ratio: 59.2% vs analyst estimates of 60.5% (1.3 percentage point beat) Adjusted EPS: $0.45 vs analyst estimates of $0.42 (8.2% beat) Market Capitalization: $10.76 billion Tracing its roots back to 1864 during the Civil War era, First Horizon (NYSE:FHN) is a Tennessee-based bank holding company that provides commercial and consumer banking, wealth management, and specialty financial services across multiple states. In general, banks make money from two primary sources. The first is net interest income, which is interest earned on loans, mortgages, and investments in securities minus interest paid out on deposits. The second source is non-interest income, which can come from bank account, credit card, wealth management, investing banking, and trading fees. Luckily, First Horizon's revenue grew at an impressive 10.4% compounded annual growth rate over the last five years. Its growth beat the average bank company and shows its offerings resonate with customers. We at StockStory place the most emphasis on long-term growth, but within financials, a half-decade historical view may miss recent interest rate changes, market returns, and industry trends. First Horizon's recent performance marks a sharp pivot from its five-year trend as its revenue has shown annualized declines of 6.3% over the last two years. Note: Quarters not shown were determined to be outliers, impacted by outsized investment gains/losses that are not indicative of the recurring fundamentals of the business. This quarter, First Horizon grew its revenue by 1.8% year on year, and its $830 million of revenue was in line with Wall Street's estimates. Net interest income made up 71.3% of the company's total revenue during the last five years, meaning lending operations are First Horizon's largest source of revenue. While banks generate revenue from multiple sources, investors view net interest income as the cornerstone - its predictable, recurring characteristics stand in sharp contrast to the volatility of non-interest income. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. The balance sheet drives banking profitability since earnings flow from the spread between borrowing and lending rates. As such, valuations for these companies concentrate on capital strength and sustainable equity accumulation potential. When analyzing banks, tangible book value per share (TBVPS) takes precedence over many other metrics. This measure isolates genuine per-share value by removing intangible assets of debatable liquidation worth. Other (and more commonly known) per-share metrics like EPS can sometimes be murky due to M&A or accounting rules allowing for loan losses to be spread out. First Horizon's TBVPS grew at a solid 6.3% annual clip over the last five years. TBVPS growth has also accelerated recently, growing by 8.6% annually over the last two years from $11.50 to $13.57 per share. Over the next 12 months, Consensus estimates call for First Horizon's TBVPS to grow by 6.5% to $14.45, mediocre growth rate. Topline metrics such as net interest income and revenue were in line, but due to better operational efficiency, EPS beat. Zooming out, we think this was a solid quarter. The stock traded up 4.1% to $22.06 immediately after reporting. Is First Horizon an attractive investment opportunity right now? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Navamedic completes dne pharma acquisition
Oslo, Norway-headquartered Navamedic has completed its previously announced acquisition of dne pharma's business for Nkr225m ($22m). This acquisition comprises dne pharma's entire business: its product portfolio, key personnel, all vital contracts, intellectual property, distribution agreements and licenses. They will be integrated into the existing commercial platform of Navamedic, aiming to facilitate rapid market access and expansion within Nordic and selected markets in Europe. The acquired products from dne pharma include Ventizolve (intranasal naloxone spray), Levopidon (levomethadone) and Metadon Dne (methadone), which is used for opioid substitution therapy. The initial transaction announced in June 2025 stated a payment of Nkr185m at closing and an additional Nkr40m dependent on future sales volumes. Navamedic CEO Kathrine Gamborg Andreassen stated: "This acquisition represents a significant step in our strategic expansion into the rapidly growing field of addiction treatment and is well aligned with our long-term growth ambitions. 'Thanks to the strong collaboration among all parties involved, the transaction was completed smoothly and efficiently. We are pleased that the General Meeting unanimously approved the rights issue yesterday, and we are sincerely grateful for the continued support of Kistefos and the other underwriters.' To finance the acquisition, Navamedic secured new debt facilities amounting to Nkr110m from Nordea Bank Abp, filial i Norge (Nordea), supplemented by equity raised through a rights issue. A bridge loan provided by Nordea facilitated the prompt completion of the deal ahead of finalising the rights issue proceeds. In arranging this transaction, Navamedic was assisted by DNB Carnegie, part of DNB Bank, and Thommessen for advisory services. Both DNB Carnegie and Nordea Corporate Finance continued as managers for the rights issue, with Thommessen continuing its role as legal advisors. dne pharma CEO Geir Ove Engeset stated: 'We are very pleased to close this transaction with Navamedic, and we are confident that the Navamedic team will continue to grow the opioid substitution business developed by dne pharma, in particular the Ventizolve products.' "Navamedic completes dne pharma acquisition" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
